ライフサイエンスコーパス: Cryptosporidium parvum

1 ctive in both in vitro and in vivo models of Cryptosporidium parvum.

2 om Escherichia coli, Bacillus anthracis, and Cryptosporidium parvum.

3 e mammalian species were similar to those of Cryptosporidium parvum.

4 nitazoxanide in treating diarrhea caused by Cryptosporidium parvum.

5 of infection by the protozoan enteropathogen Cryptosporidium parvum.

6 ted a HAPPY map of the apicomplexan parasite Cryptosporidium parvum.

7 cient mice monoassociated with the protozoan Cryptosporidium parvum.

8 biota from mice experimentally infected with Cryptosporidium parvum.

9 7, has in vitro and in vivo efficacy against Cryptosporidium parvum.

10 c-specific lectin activity in sporozoites of Cryptosporidium parvum.

11 nic E. coli, rotavirus, Giardia lamblia, and Cryptosporidium parvum.

12 ng potential waterborne pathogens, including Cryptosporidium parvum.

13 minis (65), followed by Entamoeba coli (31), Cryptosporidium parvum (17), and Entamoeba hartmanni (17

14 For Cryptosporidium parvum, 8.6% multistrain infections (13

15 lopment is a precisely programmed process in Cryptosporidium parvum, a leading cause of diarrheal dis

16 Crossing Cryptosporidium parvum, a parasite of cattle and humans,

17 ection of cultured human cholangiocytes with Cryptosporidium parvum, a parasite that causes intestina

18 RNA polymerase complexes were purified from Cryptosporidium parvum, a parasitic protozoan known to i

19 oocysts of major north Amercian isolates of Cryptosporidium parvum, a parasitic protozoan that infec

20 pply has been threatened by the emergence of Cryptosporidium parvum, a protozoal pathogen.

21 The intracellular protozoan parasite Cryptosporidium parvum accumulates host cell actin at th

22 chemical features and inhibitory kinetics of Cryptosporidium parvum ACSs using recombinant proteins.

23 Cryptosporidium parvum, an Apicomplexan parasite of the

24 Cryptosporidium parvum, an intracellular parasite, depen

25 se2) has been isolated from the apicomplexan Cryptosporidium parvum, an opportunistic pathogen of AID

26 Cryptosporidium parvum and C. hominis are parasites that

27 ly by two species of apicomplexan parasites, Cryptosporidium parvum and C. hominis.

28 eral cultured cell lines by freshly excysted Cryptosporidium parvum and Cryptosporidium hominis sporo

29 deposition of annotated genome sequences for Cryptosporidium parvum and Cryptosporidium hominis, migr

30 identify pyrazolopyridines as inhibitors of Cryptosporidium parvum and Cryptosporidium hominis.

31 d (CD40L) are unable to clear infection with Cryptosporidium parvum and develop cholangitis.

32 The rapid emergence of Cryptosporidium parvum and Escherichia coli 0157:H7 have

33 mechanism induced by the protozoan parasite Cryptosporidium parvum and Gram(-) bacteria-derived lipo

34 Cryptosporidium parvum and related species are zoonotic

35 effects of silver salt and nanoparticles on Cryptosporidium parvum and the removal of C. parvum by p

36 of two evolutionarily distant apicomplexans, Cryptosporidium parvum and Toxoplasma gondii.

37 y Giardia duodenalis, Entamoeba histolytica, Cryptosporidium parvum, and Cryptosporidium hominis Simi

38 s, Arcobacter butzleri, Helicobacter pylori, Cryptosporidium parvum, and Cyclospora, have become reco

39 notic protozoan parasites Toxoplasma gondii, Cryptosporidium parvum, and Giardia enterica with polyet

40 protozoan parasites Cyclospora cayetanensis, Cryptosporidium parvum, and microsporidia have become re

41 CDPK1 was cloned from the genome of Cryptosporidium parvum, and potent and specific inhibito

42 picomplexan protozoans Toxoplasma gondii and Cryptosporidium parvum are a major health concern.

43 Cryptosporidium hominis and Cryptosporidium parvum are associated with massive disea

44 Entamoeba histolytica, Giardia lamblia, and Cryptosporidium parvum are the most frequently identifie

45 Cryptosporidium hominis and Cryptosporidium parvum are the primary species of Crypto

46 Genotypes 1 and 2 of Cryptosporidium parvum are the primary types associated

47 ever, protozoan pathogens such as oocysts of Cryptosporidium parvum are very resistant to chlorine, w

48 ytica/E. dispar, and three were positive for Cryptosporidium parvum as determined by both methods.

49 hanisms by which microbial pathogens such as Cryptosporidium parvum associated with this syndrome act

50 Cryptosporidium parvum at various developmental stages w

51 human pathogens, Cryptosporidium hominis and Cryptosporidium parvum, but also simultaneous amplificat

52 ic chip that enables the detection of viable Cryptosporidium parvum by detecting RNA amplified by nuc

53 xed stools, which can then be used to detect Cryptosporidium parvum by nested PCR.

54 sly, we identified and characterized a novel Cryptosporidium parvum C-type lectin domain-containing m

55 s been constructed from clones isolated from Cryptosporidium parvum (C. parvum) genomic and cDNA libr

56 Altogether, 24 fecal specimens of Cryptosporidium parvum, C. hominis, C. andersoni, C. ubi

57 The three protozoan species Cryptosporidium parvum, C. meleagridis and C. hominis (p

58 Bumped kinase inhibitors (BKIs) of Cryptosporidium parvum calcium-dependent protein kinase

59 It is well known that Giardia lamblia and Cryptosporidium parvum can cause severe symptoms in huma

60 The mechanisms by which Cryptosporidium parvum cause persistent diarrhea and inc

61 The apicomplexan protozoan parasite Cryptosporidium parvum causes a diarrheal disease in hum

62 The coccidian parasite Cryptosporidium parvum causes diarrhea in humans, calves

63 Exposure to oocysts of the protozoan Cryptosporidium parvum causes intestinal epithelial cell

64 The protozoan parasite Cryptosporidium parvum causes severe enteritis with subs

65 Surprisingly, during infection by Cryptosporidium parvum, CCL20 production by the intestin

66 The protozoan parasite Cryptosporidium parvum (Cp) causes diarrhea that can be

67 whether the innate immunity of SCID mice to Cryptosporidium parvum (CP) requires IFN-gamma, doubly i

68 chronic infections of the biliary tract with Cryptosporidium parvum (CP) that may lead to biliary scl

69 Cryptosporidium parvum (CP)-infected mice have CP Ag-pos

70 Recombinant antigens of Cryptosporidium parvum, Cp900 and Cp40 but not Cp15, sti

71 IMPDH from the pathogenic protozoan parasite Cryptosporidium parvum ( CpIMPDH), which was obtained fr

72 de synthase (PKS) gene from the apicomplexan Cryptosporidium parvum (CpPKS1).

73 (i.e. short and long) of RPA1 subunits from Cryptosporidium parvum (CpRPA1A and CpRPA1B).

74 Furthermore, discrimination of Cryptosporidium parvum, Cryptosporidium muris and Giardi

75 rging pathogens, include Giardia duodenalis, Cryptosporidium parvum, Cyclospora cayetanensis, and the

76 s--Plasmodium yoelii, Toxoplasma gondii, and Cryptosporidium parvum--describing relationships between

77 es have suggested that persons infected with Cryptosporidium parvum develop antibody responses to 27-

78 The intracellular parasite Cryptosporidium parvum develops inside a vacuole at the

79 mologous loop from the apicomplexan parasite Cryptosporidium parvum does not affect TLR11-dependent I

80 rays (IMA's) during 76h and then infected by Cryptosporidium parvum during 60h.

81 ania spp, Plasmodium spp, Toxoplasma gondii, Cryptosporidium parvum, Entamoeba histolytica, Giardia l

82 eight enteropathogens (Giardia intestinalis, Cryptosporidium parvum, Entamoeba histolytica, Salmonell

83 r more gastrointestinal pathogens, including Cryptosporidium parvum, Enterocytozoon bieneusi, Mycobac

84 Cryptosporidium parvum excystation and host cell invasio

85 lleles of the highly polymorphic single-copy Cryptosporidium parvum gene Cpgp40/15.

86 To identify Cryptosporidium parvum genes expressed during intracellu

87 Recent studies, including the Cryptosporidium parvum Genome Project, have provided evi

88 Orthologues were identified in the Cryptosporidium parvum genome sequence, indicating an ev

89 A heterologous library containing Cryptosporidium parvum genomic DNA was generated, and we

90 discusses the protozoal pathogens, including Cryptosporidium parvum, Giardia lamblia, Entamoeba histo

91 gated whether a child's first infection with Cryptosporidium parvum had an acute effect on weight gai

92 These results indicate that Cryptosporidium parvum has a lasting adverse effect on l

93 Genotypic analysis of Cryptosporidium parvum has demonstrated the presence of

94 idiosis, caused by the apicomplexan parasite Cryptosporidium parvum, has become a well-recognized dia

95 that persons with AIDS who are infected with Cryptosporidium parvum have a shorter survival time than

96 Severe experimental infections with Cryptosporidium parvum have been reported in immunocompr

97 In this study, 111 Cryptosporidium parvum IId isolates from several species

98 ition, the inhibitory potential of two known Cryptosporidium parvum IMPDH inhibitors was examined for

99 ll genome data for the apicomplexan parasite Cryptosporidium parvum in a single user-friendly databas

100 nd distinguishes between Giardia lamblia and Cryptosporidium parvum in aqueous extracts of human feca

101 d- and liver-stage Plasmodium falciparum and Cryptosporidium parvum in cell-culture studies.

102 ive halogen disinfectant for inactivation of Cryptosporidium parvum in drinking water or reclaimed wa

103 and sensitive detection of viable oocysts of Cryptosporidium parvum in environmental samples was deve

104 amblia, Entamoeba histolytica/E. dispar, and Cryptosporidium parvum in fresh or fresh, frozen, unfixe

105 The half maximal effective concentration for Cryptosporidium parvum in HCT-8 cells was determined to

106 nd distinguishes between Giardia lamblia and Cryptosporidium parvum in human stool.

107 ntrolling enteric infection by the protozoan Cryptosporidium parvum in neonatal mice.

108 DNA-hybridization assay for the detection of Cryptosporidium parvum in water has been developed.

109 n of two calves with the intestinal parasite Cryptosporidium parvum induced 5- and 10-fold increases

110 We report here that the protozoan parasite Cryptosporidium parvum induced B7-H1 expression in cultu

111 on or infection with the parasitic protozoan Cryptosporidium parvum induced expression of CIS protein

112 lial lymphocyte population coincidently with Cryptosporidium parvum-induced enteric disease.

113 Our previous studies have shown that Cryptosporidium parvum induces biliary epithelial cell a

114 Cryptosporidium parvum induces moderate levels of apopto

115 liary epithelial cells (cholangiocytes) with Cryptosporidium parvum induces Toll-like receptor (TLR)

116 with the intracellular apicomplexan parasite Cryptosporidium parvum, infected and uninfected cells we

117 ynthetically labeled gp40/15 is processed in Cryptosporidium parvum-infected HCT-8 cells.

118 We have demonstrated previously that Cryptosporidium parvum infection down-regulates microRNA

119 Data about human Cryptosporidium parvum infection have originated from tr

120 effect of short-term protein malnutrition on Cryptosporidium parvum infection in a murine model by ex

121 Recovery from Cryptosporidium parvum infection in adult hosts involves

122 Resistance to and control of Cryptosporidium parvum infection in mice in the absence

123 Cryptosporidium parvum infection in the immunosuppressed

124 Resistance of adult C57BL/6 mice to severe Cryptosporidium parvum infection is dependent on CD4+alp

125 erstanding the protective immune response to Cryptosporidium parvum infection is of critical importan

126 While Cryptosporidium parvum infection of the intestine has be

127 Cryptosporidium parvum infection of the small epithelial

128 town in Lima, Peru, to examine the effect of Cryptosporidium parvum infection on child growth during

129 The impact of Cryptosporidium parvum infection on host cell gene expre

130 We previously demonstrated that Cryptosporidium parvum infection stimulates host epithel

131 ells, and B cells demonstrated resistance to Cryptosporidium parvum infection that was IFN-gamma depe

132 We used a piglet model of Cryptosporidium parvum infection to determine how elimin

133 reviously) to support long-term infection by Cryptosporidium parvum Infection was assessed by immunof

134 lation within the intestinal villi following Cryptosporidium parvum infection was characterized with

135 us reuteri as a probiotic for the control of Cryptosporidium parvum infection was evaluated in C57BL/

136 junal samples from macaques before and after Cryptosporidium parvum infection were assayed for SP and

137 y describes healing and nonhealing models of Cryptosporidium parvum infection with adult mice that ha

138 Cryptosporidium parvum infection, a common cause of diar

139 CD154 is necessary for mice to clear a Cryptosporidium parvum infection, but whether this ligan

140 To clear a Cryptosporidium parvum infection, mice need CD4+ T cells

141 fection, Pneumocystis carinii pneumonia, and Cryptosporidium parvum infection.

142 nd activity against Pneumocystis carinii and Cryptosporidium parvum infections in vivo compared to th

143 Cryptosporidium parvum infects intestinal epithelial cel

144 The protozoan parasite Cryptosporidium parvum invades intestinal epithelial cel

145 Cryptosporidium parvum invades target epithelia via a me

146 Cryptosporidium parvum invasion of epithelia requires po

147 Cryptosporidium parvum invasion of epithelial cells invo

148 s only had access to a good, but incomplete, Cryptosporidium parvum IOWA reference genome sequence.

149 Cryptosporidium parvum is a coccidian parasite responsib

150 Cryptosporidium parvum is a coccidian protozoan that cau

151 The zoonotic parasite Cryptosporidium parvum is a global cause of gastrointest

152 The protozoan parasite Cryptosporidium parvum is a leading cause of diarrhea in

153 Cryptosporidium parvum is a major cause of diarrheal ill

154 The apicomplexan parasite Cryptosporidium parvum is a major cause of serious diarr

155 tion of the intestinal and biliary tracts by Cryptosporidium parvum is a major problem in patients wi

156 Cryptosporidium parvum is a minimally invasive protozoal

157 Cryptosporidium parvum is a potential biowarfare agent,

158 The protozoan parasite Cryptosporidium parvum is a significant cause of diarrhe

159 Cryptosporidium parvum is a significant cause of diarrhe

160 Because of its oocyst durability Cryptosporidium parvum is a significant water- and food-

161 Cryptosporidium parvum is a waterborne enteric coccidian

162 Cryptosporidium parvum is a waterborne pathogen, yet no

163 Cryptosporidium parvum is a zoonotic apicomplexan parasi

164 Cryptosporidium parvum is an enteric protozoan parasite

165 The protozoan parasite Cryptosporidium parvum is an important cause of diarrhea

166 Cryptosporidium parvum is an important cause of diarrhea

167 Cryptosporidium parvum is an important cause of epidemic

168 Cryptosporidium parvum is an important diarrhea-causing

169 Cryptosporidium parvum is an important human pathogen an

170 Cryptosporidium parvum is an important opportunistic par

171 Cryptosporidium parvum is an important pathogen that cau

172 The apicomplexan Cryptosporidium parvum is an intestinal parasite that af

173 Cryptosporidium parvum is an intracellular protozoan par

174 Cryptosporidium parvum is an intracellular protozoan par

175 Cryptosporidium parvum is an obligate intracellular para

176 Cryptosporidium parvum is an obligate intracellular path

177 Cryptosporidium parvum is an obligate intracellular prot

178 Cryptosporidium parvum is an opportunistic pathogen in A

179 The apicomplexan Cryptosporidium parvum is one of the most prevalent prot

180 Cryptosporidium parvum is recognized as an enteropathoge

181 Cryptosporidium parvum is usually considered to be the p

182 Waterborne transmission of Cryptosporidium parvum is well-established as a source i

183 idiosis, caused by the apicomplexan parasite Cryptosporidium parvum, is a diarrheal disease that has

184 Cryptosporidiosis, caused by Cryptosporidium parvum, is self-limited in immunocompete

185 The infectivity of a Cryptosporidium parvum isolate of cervine origin (type 2

186 We report a genomic analysis of Cryptosporidium parvum isolated from Bangladeshi infants

187 The infectivity of three Cryptosporidium parvum isolates (Iowa [calf], UCP [calf]

188 tudy, we use classical genetics to cross two Cryptosporidium parvum isolates of different virulence a

189 Cryptosporidium parvum, Isospora belli, Cyclospora cayet

190 Cryptosporidium parvum, Leishmania spp., Trypanosoma cru

191 the gene expression programme of the entire Cryptosporidium parvum life cycle in culture and in infe

192 olymorphic proteins and found members of the Cryptosporidium parvum MEDLE protein family to be transl

193 asite Toxoplasma gondii, outlines a detailed Cryptosporidium parvum metabolic map and facilitates cel

194 notype 1 (HuG1) and bovine genotype 2 (BoG2) Cryptosporidium parvum, neonatal gnotobiotic pigs were g

195 uantitative detection of Giardia lamblia and Cryptosporidium parvum (oo)cysts in a field campaign.

196 surface charge heterogeneity on transport of Cryptosporidium parvum oocyst and carboxylate microspher

197 om three asymptomatic horses and seeded with Cryptosporidium parvum oocysts (10(1) to 10(6)/g of fece

198 from pathogens such as Escherichia coli and Cryptosporidium parvum oocysts account for most of the c

199 Transport of Cryptosporidium parvum oocysts and microspheres in two d

200 cJ nude mice following oral inoculation with Cryptosporidium parvum oocysts at 8 to 9 weeks of age.

201 Effective removal of Cryptosporidium parvum oocysts by granular filtration re

202 r the detection of mRNA targets derived from Cryptosporidium parvum oocysts by the use of oligonucleo

203 Protein-deficient mice were infected with Cryptosporidium parvum oocysts for 6-13 days and compare

204 Three methods of isolating Cryptosporidium parvum oocysts from rat feces were evalu

205 , Wisconsin, in April 1993 was attributed to Cryptosporidium parvum oocysts in drinking water.

206 hallenge of accurately and rapidly detecting Cryptosporidium parvum oocysts in environmental water, t

207 vitro and in vivo) and unexcysted (in vivo) Cryptosporidium parvum oocysts in human colonic adenocar

208 Ruthenium red staining of Cryptosporidium parvum oocysts revealed the presence of

209 e and detect both Escherichia coli cells and Cryptosporidium parvum oocysts that have been embedded i

210 riments was performed with freshly harvested Cryptosporidium parvum oocysts to evaluate the effects o

211 ore, the induced expression of HSP70 mRNA in Cryptosporidium parvum oocysts via a simple heat shock p

212 nfected by the oral administration of 50,000 Cryptosporidium parvum oocysts, and the resulting infect

213 as milligrams per liter) for disinfection of Cryptosporidium parvum oocysts, Bacillus atrophaeus spor

214 sceptible to infection with small numbers of Cryptosporidium parvum oocysts, resulting in self-limite

215 nse in 26 healthy volunteers challenged with Cryptosporidium parvum oocysts.

216 s nor the monoclonal antibodies reacted with Cryptosporidium parvum oocysts.

217 ase-patients had a stool specimen containing Cryptosporidium parvum oocysts.

218 ing-wall vessel (RWV) and were infected with Cryptosporidium parvum oocysts.

219 ndii, Neospora caninum, Leishmania infantum, Cryptosporidium parvum, or canine DNA under any of the c

220 cholangiocytes with the protozoan parasite, Cryptosporidium parvum, or treatment with gram-negative

221 Cryptosporidium parvum parasitizes intestinal epithelium

222 The apicomplexan pathogen Cryptosporidium parvum poses major logistical problems i

223 Cryptosporidium parvum preferentially infects epithelial

224 ight subtypes of Cryptosporidium hominis and Cryptosporidium parvum present, allele Ib was found in 1

225 human intestinal epithelial cells (HCT-8) by Cryptosporidium parvum resulted in a rapid induction of

226 bligate intracellular apicomplexan parasite, Cryptosporidium parvum, results in the formation of a un

227 We show that Cryptosporidium parvum splits into two subclades and tha

228 mechanisms of apical organelle discharge by Cryptosporidium parvum sporozoites and its role in host

229 sed cryo-electron tomography to image motile Cryptosporidium parvum sporozoites and reveal the cellul

230 Caco-2A was developed to study attachment of Cryptosporidium parvum sporozoites in vitro and to asses

231 study interactions of MBL and complement on Cryptosporidium parvum sporozoites.

232 Cryptosporidium parvum subtypes differ in pathogenicity,

233 ble to infection with the protozoan parasite Cryptosporidium parvum than were control mice.

234 odium falciparum, the parasitic Apicomplexan Cryptosporidium parvum, the yeast Saccharomyces cerevisi

235 Fifty-eight of the children (94%) had Cryptosporidium parvum, three (5%) had Cryptosporidium h

236 rasitic chemotherapy, but the human pathogen Cryptosporidium parvum thus far has proved extraordinari

237 ge of newly available molecular genetics for Cryptosporidium parvum to investigate nucleotide biosynt

238 0-kDa integral membrane protein, CpABC, from Cryptosporidium parvum to the host-parasite boundary, po

239 Infection of epithelial cells by Cryptosporidium parvum triggers a variety of host-cell i

240 Cryptosporidium parvum TU502, a genotype 1 isolate of hu

241 Human infection with Cryptosporidium parvum usually elicits characteristic im

242 Cryptosporidium parvum virus 1 (CSpV1) is a double-stran

243 Cryptosporidium parvum was detected in stool specimens o

244 feron-gamma (IFN-gamma) against infection by Cryptosporidium parvum was evaluated in immunosuppressed

245 .8-kb threonine-rich open reading frame from Cryptosporidium parvum was identified and used to determ

246 gondii, Plasmodium falciparum (malaria) and Cryptosporidium parvum was inhibited by the herbicide gl

247 Excellent in vitro activity against Cryptosporidium parvum was observed for both classes of

248 The hsp70 mRNA from Cryptosporidium parvum was used as a model analyte.

249 endent pathways play a role in resistance to Cryptosporidium parvum, we compared the course of infect

250 o diarrhoea prevalence, Giardia lamblia, and Cryptosporidium parvum were adjusted for severe stunting

251 Biopsies from volunteers challenged with Cryptosporidium parvum were examined for transforming gr

252 nal biopsies from volunteers challenged with Cryptosporidium parvum were examined for tumor necrosis

253 Recombinant progeny lines of Cryptosporidium parvum were generated by coinfecting imm

254 smodium falciparum, Plasmodium knowlesi, and Cryptosporidium parvum were sequenced.

255 invasion by an early-branching apicomplexan, Cryptosporidium parvum, which causes diarrheal disease i

256 Cryptosporidium parvum, which causes intractable diarrhe

257 Cryptosporidium hominis and Cryptosporidium parvum, which infect humans equally, are

258 ng for Giardia intestinalis (G. lamblia) and Cryptosporidium parvum, with a priority being placed on